Navigation Links
Neurochem announces departure of two members of management team
Date:2/21/2008

LAVAL, QC, Feb. 21 /PRNewswire-FirstCall/ - In light of Neurochem Inc.'s (NASDAQ: NRMX; TSX: NRM) new strategic direction, the Company announces the departure, effective February 21, 2008, of two members of its senior management team, Dr. Andreas Orfanos, MBB. Ch, MBA, Executive Vice President, Strategic Planning and Scientific Affairs, and Ms. Christine Lennon, MBA, Vice President, Business Development. The possibility of their acting as consultants in respect of specific projects is being explored.

"On behalf of the Board of Directors and my colleagues, I want to express our gratitude to Dr. Orfanos and Ms. Lennon for their dedication and valuable contribution to Neurochem. We wish them every success in the future," said Dr. Francesco Bellini, Neurochem's Chairman, President and CEO.

About Neurochem

Neurochem Inc. is a global health company focused on the research, development and commercialization of products to provide innovative health solutions to address critical unmet medical needs.

To Contact Neurochem

For additional information on Neurochem and its drug development programs, please call the North American toll-free number 1-877-680-4500 or visit our Web Site at http://www.neurochem.com.

Certain statements contained in this news release, other than statements of fact that are independently verifiable at the date hereof, may constitute forward-looking statements. Such statements, based as they are on the current expectations of management, inherently involve numerous risks and uncertainties, known and unknown, many of which are beyond Neurochem Inc.'s control. Such risks include but are not limited to: the impact of general economic cond
'/>"/>

SOURCE NEUROCHEM INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives
2. Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live
3. Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business
4. Neurochem to present at JPMorgan Healthcare Conference
5. Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
6. Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 review
7. Neurochem announces departure of Dr. Philippe Calais, President, Global Business
8. Neurochem reports results for third quarter of fiscal 2007
9. Emergency Dentist 24/7(TM) Announces Worldwide Licensing Program
10. LCA-Vision Announces Quarterly Dividend Payment
11. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... Now that Thanksgiving is finally here ... Emassagechair.com has announced its eagerly awaited, once ... , Negotiating on behalf of their customers, and drawing ... Emassagechair.com has generated significant buzz in the industry with ... yet. , Shoppers are excited for significant savings available ...
(Date:11/27/2014)... “LAB.C” was featured on NewsWatch as part of its ... products available to consumers. Mallory Sofastaii, a technology expert and ... shared with viewers the company offers a cable case, iBed, ... love portability and functionality. A unique mobile company at ... and 5S has a portable USB charger built in. The ...
(Date:11/27/2014)... Philadelphia, PA (PRWEB) November 27, 2014 ... alongside volunteer Aria Health employees, prepared and donated ... to the Lutheran Settlement House , a non-profit, ... and families living in Philadelphia. The dinners were ... Settlement House Senior Center, and distributed to vulnerable ...
(Date:11/27/2014)... New Delhi, India (PRWEB) November 27, 2014 ... internet marketing company, has announced online reputation management ... after doing a comprehensive study about the world of ... Google, Bing, and Yahoo. , Ethane Web Technologies ... project. Instead, it first analyzes the project to reach ...
(Date:11/27/2014)... In addition to a new dessert recipe or family ... season and become educated about the warning signs of ... holidays may raise questions about the physical and cognitive ... ability can occur with age, serious memory problems are ... between normal aging and more serious problems can help ...
Breaking Medicine News(10 mins):Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 4Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2Health News:Aria Health Prepares and Donates 200 Thanksgiving Dinners 2Health News:Ethane Web Technologies Announces Online Reputation Management Service 2Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 2Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 3Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 4Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 5
... Nurse Practitioner and herbalist announces her first product, Omyst™, a healing ... successfully tested on over 2,000 patients and has been clinically proven ... insect bites, stings and sutures. , ... New York, ...
... is committed to bringing new acai health product reviews to the masses ... available on the market today. , ... Green Bay, WI (PRWEB) November ... new acai health product reviews to the masses by providing accurate descriptions ...
... WARSAW, Ind., Nov. 6 Zimmer Holdings, Inc.,(NYSE: ... it has become the founding,supporter of a new ... provide funding for post-graduate orthopaedic fellowships and,residency programs, ... entity, called OMeGA Medical Grants Association LLC (OMeGA),will ...
... 6 Lumenis(R) Ltd. a global,developer, manufacturer and ... surgical and aesthetic applications,announced today that it will ... November 8th at the American Academy of Ophthalmology,(AAO) ... Lumenis, President and Chief Executive Officer stated:,"Lumenis is ...
... 6 The following was released today,by Dr. ... report from the U.S. Department of Veterans Affairs ... waste,mismanagement and inaction to disclosures of fraud, waste, ... Veterans Health,Care System (CTVHCS)., Inaction to these ...
... (Nasdaq: MBRK ), a pharmaceutical company focused ... three patents protecting Moxatag (amoxicillin,extended-release) Tablets, 775mg, were ... 2008, pursuant to Section 4 of Public Law ... MiddleBrook President & CEO John Thievon said, ...
Cached Medicine News:Health News:Nurse Practitioner Creates Healing Herbal First-aid Spray 2Health News:Nurse Practitioner Creates Healing Herbal First-aid Spray 3Health News:Acai Berry Health Foods Heightens Consumer Awareness of the Purple Miracle Berry 2Health News:Zimmer Holdings to Collaborate with the American Orthopaedic Association for Funding Post-Graduate Medical Education 2Health News:Zimmer Holdings to Collaborate with the American Orthopaedic Association for Funding Post-Graduate Medical Education 3Health News:Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA 2Health News:Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA 3Health News:Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA 4Health News:War Veterans With Traumatic Brain Injury Pay the Price of Waste at the VA, Says Dr. Robert Van Boven 2Health News:MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents 2Health News:MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents 3Health News:MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents 4
(Date:11/26/2014)... LOVELAND, Colo. , Nov. 25, 2014   Heska ... ; "Heska" or the "Company"), a provider of advanced ... Dr. Robert Grieve , Executive Chair, will attend The ... 11, 2014. The one-on-one conference will be held at The ... IL from 8 a.m. to 2:30 p.m. Please ...
(Date:11/26/2014)... LONDON , Nov. 25, 2014 Amgen (NASDAQ: ... ) today announced that AMAGINE-2 TM , a pivotal, multi-arm ... than 1,800 patients with moderate-to-severe plaque psoriasis, met its primary ... placebo at week 12. Brodalumab 210 mg given every two ... to be superior to Stelara on the primary endpoint of ...
(Date:11/26/2014)... China , Nov. 26, 2014 / -- China Nepstar Chain ... "Company"), a leading retail drugstore chain in ... operated stores, today announced the appointment of Ms. ... Officer, effective immediately. Ms.Zhang has over ... joined Nepstar in March 1999. Prior to Ms. Zhang,s ...
Breaking Medicine Technology:Heska to Attend Benchmark Micro Cap Discovery Conference 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer 2China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer 3
... of treating upper extremity fractures with ... many studies. , ,Intramedullary nailing using ... offers the benefits of anatomic alignment, ... dissection and early rehabilitation of the ...
... An innovative new system to help you ... The system's one-piece design creates a ... enhances postoperative radiographic assessment. The slotted superior ... the central column and are flared outward ...
... The QuickSite model 1056K LV lead ... and to promote shorter procedure times, ... performance, and reliability., ,The QuickSite LV ... advanced left ventricular lead, including such ...
... The AIM Titanium Tibial Nail ... the mechanical failures of existing ... for tibial interlocking nails. It ... range of diameters and lengths ...
Medicine Products: